|
|
||||||||
AJP - Heart and Circulatory Physiology, Vol 271, Issue 3 1132-H1138, Copyright © 1996 by American Physiological Society
ARTICLES |
R. A. Johnson, M. Lavesa, K. DeSeyn, M. J. Scholer and A. Nasjletti
Department of Pharmacology, New York Medical College, Valhalla 10595, USA.
Heme oxygenase catalyzes the metabolism of heme to biliverdine, free iron, and carbon monoxide. The current study was designed to determine if treatment with the heme oxygenase substrates heme-L-arginate or heme-L-lysinate, to stimulate formation of heme oxygenase products, can lower blood pressure in the rat. Heme-L-arginate (45 mumol/kg ip) and heme-L-lysinate (45 mumol/kg ip) acutely lowered blood pressure in awake spontaneously hypertensive rats (SHR) by approximately 35 mmHg. For both heme oxygenase substrates, this effect was blunted by pretreatment with an inhibitor of heme oxygenase, zinc deuteroporphyrin 2,4-bis glycol. Heme-L-lysinate also lowered arterial pressure in deoxycorticosterone acetate-salt hypertensive rats and in rats with phenylephrine-induced hypertension, indicating that the vasodepressive actions of heme may be extended to other hypertensive models. However, neither heme-L-arginate nor heme-L-lysinate decreased blood pressure in normotensive controls. The heme oxygenase product biliverdine did not lower blood pressure in SHR, and the vasodepressive actions of heme-L-lysinate were unaffected by pretreatment with deferoxamine to chelate free iron. Carbon monoxide (12 ml/kg ip) lowered blood pressure in SHR and in rats made hypertensive by phenylephrine infusion, had no effect on blood pressure in Wistar-Kyoto rats, and elicited only a modest vasodepressive response in normotensive Sprague-Dawley rats. We conclude that heme-bearing preparations can lower blood pressure in hypertensive rats, presumably via heme oxygenase-mediated formation of carbon monoxide.
This article has been cited by other articles:
![]() |
N. G. Abraham, J. Cao, D. Sacerdoti, X. Li, and G. Drummond Heme oxygenase: the key to renal function regulation Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1137 - F1152. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jadhav, E. Torlakovic, and J. F. Ndisang Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats Am J Physiol Renal Physiol, March 1, 2009; 296(3): F521 - F534. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Nath, L. V. d'Uscio, J. P. Juncos, A. J. Croatt, M. C. Manriquez, S. T. Pittock, and Z. S. Katusic An analysis of the DOCA-salt model of hypertension in HO-1-/- mice and the Gunn rat Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H333 - H342. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, I. Armando, L. D. Asico, C. Escano, X. Wang, Q. Lu, R. A. Felder, C. G. Schnackenberg, D. R. Sibley, G. M. Eisner, et al. The elevated blood pressure of human GRK4{gamma} A142V transgenic mice is not associated with increased ROS production Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2083 - H2092. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-C. Lo, P.-J. Lu, W.-Y. Ho, M. Hsiao, and C.-J. Tseng Induction of Heme Oxygenase-1 Is Involved in Carbon Monoxide-Mediated Central Cardiovascular Regulation J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 8 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Ryter, J. Alam, and A. M. K. Choi Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications Physiol Rev, April 1, 2006; 86(2): 583 - 650. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wu and R. Wang Carbon Monoxide: Endogenous Production, Physiological Functions, and Pharmacological Applications Pharmacol. Rev., December 1, 2005; 57(4): 585 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nishikawa, D. W. Stepp, D. Merkus, D. Jones, and W. M. Chilian In vivo role of heme oxygenase in ischemic coronary vasodilation Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2296 - H2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wang, H. Sterling, W. A. Shao, Q. Yan, M. A. Bailey, G. Giebisch, and W.-H. Wang Inhibition of heme oxygenase decreases sodium and fluid absorption in the loop of Henle Am J Physiol Renal Physiol, September 1, 2003; 285(3): F484 - F490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Naik and B. R. Walker Heme oxygenase-mediated vasodilation involves vascular smooth muscle cell hyperpolarization Am J Physiol Heart Circ Physiol, June 5, 2003; 285(1): H220 - H228. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Fiumana, H. Parfenova, J. H. Jaggar, and C. W. Leffler Carbon monoxide mediates vasodilator effects of glutamate in isolated pressurized cerebral arterioles of newborn pigs Am J Physiol Heart Circ Physiol, April 1, 2003; 284 (4): H1073 - H1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Naik, T. L. O'Donaughy, and B. R. Walker Endogenous carbon monoxide is an endothelial-derived vasodilator factor in the mesenteric circulation Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H838 - H845. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Durante Carbon monoxide and bile pigments: surprising mediators of vascular function Vascular Medicine, August 1, 2002; 7(3): 195 - 202. [Abstract] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Steiner and L. G. S. Branco Carbon monoxide is the heme oxygenase product with a pyretic action: evidence for a cGMP signaling pathway Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2001; 280(2): R448 - R457. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Aizawa, N. Ishizaka, J.-i. Taguchi, R. Nagai, I. Mori, S.-S. Tang, J. R. Ingelfinger, and M. Ohno Heme Oxygenase-1 Is Upregulated in the Kidney of Angiotensin II-Induced Hypertensive Rats : Possible Role in Renoprotection Hypertension, March 1, 2000; 35(3): 800 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-P. Zou, H. Billington, N. Su, and A. W. Cowley Jr Expression and Actions of Heme Oxygenase in the Renal Medulla of Rats Hypertension, January 1, 2000; 35(1): 342 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Thorup, C. L. Jones, S. S. Gross, L. C. Moore, and M. S. Goligorsky Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS Am J Physiol Renal Physiol, December 1, 1999; 277(6): F882 - F889. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. D. T. G. Wagener, J.-L. da Silva, T. Farley, T. de Witte, A. Kappas, and N. G. Abraham Differential Effects of Heme Oxygenase Isoforms on Heme Mediation of Endothelial Intracellular Adhesion Molecule 1 Expression J. Pharmacol. Exp. Ther., October 1, 1999; 291(1): 416 - 423. [Abstract] [Full Text] |
||||
![]() |
J. C. McGiff and J. Quilley 20-HETE and the kidney: resolution of old problems and new beginnings Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R607 - R623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Steiner, E. Colombari, and L. G. S. Branco Carbon monoxide as a novel mediator of the febrile response in the central nervous system Am J Physiol Regulatory Integrative Comp Physiol, August 1, 1999; 277(2): R499 - R507. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kozma, R. A. Johnson, F. Zhang, C. Yu, X. Tong, and A. Nasjletti Contribution of endogenous carbon monoxide to regulation of diameter in resistance vessels Am J Physiol Regulatory Integrative Comp Physiol, April 1, 1999; 276(4): R1087 - R1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Motterlini, A. Gonzales, R. Foresti, J. E. Clark, C. J. Green, and R. M. Winslow Heme Oxygenase-1–Derived Carbon Monoxide Contributes to the Suppression of Acute Hypertensive Responses In Vivo Circ. Res., September 7, 1998; 83(5): 568 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Johnson, E. Colombari, D. S. A. Colombari, M. Lavesa, W. T. Talman, and A. Nasjletti Role of Endogenous Carbon Monoxide in Central Regulation of Arterial Pressure Hypertension, October 1, 1997; 30(4): 962 - 967. [Abstract] [Full Text] |
||||
![]() |
P. Wiesel, A. P. Patel, I. M. Carvajal, Z. Y. Wang, A. Pellacani, K. Maemura, N. DiFonzo, H. G. Rennke, M. D. Layne, S.-F. Yet, et al. Exacerbation of Chronic Renovascular Hypertension and Acute Renal Failure in Heme Oxygenase-1-Deficient Mice Circ. Res., May 25, 2001; 88(10): 1088 - 1094. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imai, T. Morita, T. Shindo, R. Nagai, Y. Yazaki, H. Kurihara, M. Suematsu, and S. Katayama Vascular Smooth Muscle Cell-Directed Overexpression of Heme Oxygenase-1 Elevates Blood Pressure Through Attenuation of Nitric Oxide-Induced Vasodilation in Mice Circ. Res., July 6, 2001; 89(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |